The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections

Journal of Infection

Volumn 69, Issue 3, 2014, Pages 278-283

  Rose, Stacey R ^a   Vallabhajosyula, Saraschandra ^a   Velez, Miguel G ^a   Fedorko, Daniel P ^b   VanRaden, Mark J ^a   Gea Banacloche, Juan C ^c   Lionakis, Michail S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aspergillosis; Beta D glucan; Bronchoalveolar lavage; Galactomannan; Invasive fungal infection

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIBIOTIC AGENT; BETA DEXTRO GLUCAN; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; GALACTOMANNAN; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; POLYSACCHARIDE; POSACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE; BETA GLUCAN; MANNAN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRONCHOALVEOLAR LAVAGE BETA DEXTRO GLUCAN TESTING; BRONCHOALVEOLAR LAVAGE GALACTOMANNAN TESTING; CARBOHYDRATE ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTEMIC MYCOSIS; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; FUSARIOSIS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG DISEASES, FUNGAL; MICROBIOLOGY; MUCORMYCOSIS; PAECILOMYCES; PNEUMONIA, PNEUMOCYSTIS; SCOPULARIOPSIS;

BETA-GLUCANS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FUSARIOSIS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG DISEASES, FUNGAL; MALE; MANNANS; MUCORMYCOSIS; PAECILOMYCES; PNEUMONIA, PNEUMOCYSTIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SCOPULARIOPSIS; SENSITIVITY AND SPECIFICITY;

EID: 84922399139     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.04.008     Document Type: Article

References (13)

1. Ostrosky-Zeichner Lss. Invasive mycoses: diagnostic challenges. Am J Med 2012, 125(1 Suppl.):S14-S24.
2. Tarrand J., Lichterfeld M., Warraich I., Luna M., Han X.Y., May G.S., et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003, 119(6):854-858.
3. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46(12):1813-1821.
4. Pfeiffer C.D., Fine J.P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006, 42(10):1417-1427.
5. Karageorgopoulos D.E., Vouloumanou E.K., Ntziora F., Michalopoulos A., Rafailidis P.I., Falagas M.E. ß-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011, 52(6):750-770.
6. Ostrosky-Zeichner L., Alexander B.D., Kett D.H., Vazquez J., Pappas P.G., Saeki F., et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41(5):654-659.
7. Zou M., Tang L., Zhao S., Zhao Z., Chen L., Chen P., et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLos One 2012, 7(8):e43347.
8. Segal B.H., Herbrecht R., Stevens D.A., Ostrosky-Zeichner L., Sobel J., Viscoli C., et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008, 47(5):674-683.
9. Karageorgopoulos D.E., Qu J.M., Korbila I.P., Zhu Y.G., Vasileiou V.A., Falagas M.E. Accuracy of ß-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect 2013, 19(1):39-49.
10. Theel E.S., Jespersen D.J., Iqbal S., Bestrom J.E., Rollins L.O., Misner L.J., et al. Detection of (1,3)-ß-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia 2013, 175(1-2):33-41.
11. Tasaka S., Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV infected patients in the era of novel immunosuppressive therapies. J Infect Chemother 2012, 18(6):793-806.
12. Fisher C.E., Stevens A.M., Leisenring W., Pergam S.A., Boeckh M., Hohl T.M. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis 2013, 57(7):1001-1004.
13. Jones K.P., Edwards J.H., Reynolds S.P., Peters T.J., Davies B.H. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease. Eur Respir J 1990, 3(2):152-156.